IRCT20141025019669N12已完成3 期
Assessment of the ellagic acid supplementation effect on insulin resistance, oxidative stress and sex hormones levels in women with the Polycystic ovary syndrome.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 45 years（—）
- 性别
- Female
入选标准
- •Women with the poly cystic ovarian syndrome
排除标准
- •Use of contraceptives, glucocorticoids and lipid lowering drugs over the past three months
研究者
相似试验
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation effect in patients with type 2 diabetesIRCT20141025019669N13Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in patient with irritabe bowel syndromeIrritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141025019669N11Qazvin University of Medical Sciences44
尚未招募
3 期
Ellagic acid in multiple sclerosisMultiple sclerosisIRCT20120415009472N22Iran University of Medical Sciences46